Immune responses and long ‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia

CONCLUSIONSThe generation of hTERT‐DCs is feasible and vaccination with hTERT‐DCs appears to be safe and may be associated with favorable recurrence‐free survival. Cancer 2017. © 2017 American Cancer Society.

Source: Cancer - April 14, 2017 Category: Cancer & Oncology Authors: Hanna J. Khoury, Robert H. Collins, William Blum, Patrick S. Stiff, Laurence Elias, Jane S. Lebkowski, Anita Reddy, Kevin P. Nishimoto, Debasish Sen, Edward D. Wirth, Casey C. Case, John F. DiPersio Tags: Original Article Source Type: research